Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
The New England Journal of Medicine|May 1, 1998
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'ImmunothérapieS Negrier, B Escudier, C Lasset, et al.European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)C Delbaldo, D Serin, M Mousseau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patientsY Bécouarn, E Gamelin, B Coudert, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of anthracyclines in the treatment of advanced ovarian cancerH J Lück, A Du Bois, B Weber, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical dataM Chazal, S Cheradame, J L Formento, et al.Seminars in Oncology|November 5, 1997
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II studyE Pujade-Lauraine, J P Guastalla, B Weber, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II studyJ P Guastalla, E Pujade-Lauraine, B Weber, et al.European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomyE Pujade-Lauraine, J P Guastalla, N Colombo, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]F Mornex, L Thomas, P Mohr, et al.Pageof 6